Agillic A/S
Notice to annual general meeting in Agillic A/S
Notice to annual general meeting in Agillic A/S
Announcement no. 4 - 2025
Copenhagen – 18 March 2025 – Agillic A/S
Notice is hereby given to shareholders in Agillic A/S of the annual general meeting scheduled for 3 April 2025 at 14:30 (CET).
The general meeting is held at the company’s address at Masnedøgade 22, 2, DK-2100 Copenhagen.
Enclosed please find notice and agenda for the annual general meeting.
For further information, please contact:
Christian Samsø, CEO
+45 24 88 24 24
Christian.samsoe@agillic.com
Certified Adviser
HC Andersen Capital
Pernille Friis Andersen
About Agillic A/S
Agillic (Nasdaq First North Growth Market Denmark: AGILC) is a Danish software company offering brands a platform through which they can work with data-driven insights and content to create, automate and send personalised communication to millions. Agillic is headquartered in Copenhagen, Denmark. For further information, please visit www.agillic.com.
Attachments
- Blanket til bestilling af adgangskort - Form for ordering of admission card
- Appendix 1 - Bestyrelseskandidater - Board candidates
- Fuldmagts- og brevstemmeblanket - proxy and postal vote form
- Indkaldelse til ordinaer generalforsamling - notice to ordinary general meeting
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CNH Industrial N.V.18.3.2025 23:00:00 CET | Press release
Pricing of CNH Industrial Capital LLC $500 million notes
Nokia Oyj18.3.2025 21:30:00 CET | Press release
Nokia Corporation: Repurchase of own shares on 18.03.2025
SoftServe, Inc18.3.2025 21:01:00 CET | Press release
SoftServe Prepares Enterprises for Next AI Stages with New Agentic AI Solution at NVIDIA GTC
Magna International Inc.18.3.2025 21:00:00 CET | Press release
Magna and NVIDIA Team Up to Advance Next-Gen Automotive Technologies
BioAegis Therapeutics18.3.2025 19:25:01 CET | Press release
BioAegis Therapeutics to Highlight Lead Product Gelsolin’s Critical Role in Immune Function at Upcoming Conferences
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom